Human Health | Boehringer Ingelheim AT

Human Health

Boehringer Ingelheim is a research-driven group of companies dedicated to the discovery, development, manufacture and marketing of innovative healthcare products.

How we discover our medicines

[Read more](/content/at/en/science-innovation/human-health-innovation/drug-discovery-boehringer-ingelheim "Teaser headline How we discover our medicines"/index.html)

Schizophrenia in real life: Stories of challenges, resilience and hope

Through these real-life stories, discover the eye-opening reality of life with schizophrenia.

[Interstitial Lung Diseases - Sound the ILD Alarm](/content/at/en/human-health/lung-diseases/interstitial-lung-diseases-sound-ild-alarm "Interstitial Lung Diseases - Sound the ILD Alarm"/index.html)

Interstitial Lung Diseases - Sound the ILD Alarm

Learn more about ILDs and why it's important to ‘sound the ILD alarm’ for early detection and treatment.

[We are there for our patients – even in crisis regions.](/content/at/en/human-health/we-are-there-our-patients-even-crisis-regions "We are there for our patients – even in crisis regions."/index.html)

We ensure that patients get the medication they need. We maintain our supply chain despite rising global challenges around the world.

Further Topics

Heart Diseases

Cardiovascular disease, including heart disease and stroke, is a major global health concern and the leading cause of death and disability worldwide.

Metabolic Diseases

Interconnected cardio-renal-metabolic conditions – affecting the heart, kidneys, and metabolic system – are the leading cause of mortality worldwide and account for up to 20 million deaths annually.

Chronic Kidney Disease

Chronic Kidney Disease, or CKD, is caused by progressive damage to the kidneys, affecting 10% of the population.

Cancer

Cancer takes. Takes away time. Takes away loved ones. At Boehringer Ingelheim we are providing new hope for patients by taking cancer on.

Lung Diseases

Boehringer Ingelheim has 100 years of heritage in respiratory disease. Since 1921 we have emerged as a leader in this disease area.

Mental Health

Boehringer Ingelheim has a range of different compounds in development for Central Nervous System (CNS) diseases, some in advanced clinical phases.

Retinal Diseases

At Boehringer Ingelheim, we have expanded our global research and development activities to tackle eye diseases. Visual impairment and blindness have a profound and devastating impact on the lives of the affected person.

Our Responsibility

The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier, too. By delivering value through innovation, we enhance the well-being of both.